Internal Medicine — Old Core Academic Day Lectures (Until Sep 2023)
Neutropenic fever and infections in immunocompromised patients including HIV
Teaching
Competencies covered in this activity
| 1. Practise medicine within their defined scope of practice and expertise | ||||||
| 1.4. Apply knowledge of the following systems, clinical scenarios, conditions, diseases and therapies applicable to Internal Medicine, including the manifestations, investigation, and management | ||||||
| 1.4.12. Infection | ||||||
| 1.4.12.1. Disorders | ||||||
| 1.4.12.1.1. Infective endocarditis | ||||||
| 1.4.12.1.2. Pneumonia | ||||||
| 1.4.12.1.3. Infectious diarrhea | ||||||
| 1.4.12.1.4. Clostridium difficile colitis | ||||||
| 1.4.12.1.5. Intra-abdominal infections | ||||||
| 1.4.12.1.6. Urosepsis | ||||||
| 1.4.12.1.7. Meningitis and encephalitis | ||||||
| 1.4.12.1.8. Bone and joint infections | ||||||
| 1.4.12.1.9. Cellulitis and other skin infections | ||||||
| 1.4.12.1.10. Necrotizing soft tissue infections | ||||||
| 1.4.12.1.11. Fever of unknown origin | ||||||
| 1.4.12.1.12. Fever in the immuno-compromised host | ||||||
| 1.4.12.1.13. Fever in the hospitalized patient | ||||||
| 1.4.12.1.14. Fever, skin diseases, and diarrhea in the returning traveler | ||||||
| 1.4.12.1.15. Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and its treatment and complications, including but not limited to: | ||||||
| 1.4.12.1.15.1. Fever | ||||||
| 1.4.12.1.15.2. Weight loss | ||||||
| 1.4.12.1.15.3. Dyspnea, cough, hemoptysis | ||||||
| 1.4.12.1.15.4. Dysphagia, diarrhea | ||||||
| 1.4.12.1.15.5. Anemia, neutropenia, thrombocytopenia | ||||||
| 1.4.12.1.15.6. Metabolic derangements | ||||||
| 1.4.12.1.15.7. Opportunistic infections | ||||||
| 1.4.12.1.16. Malaria | ||||||
| 1.4.12.1.17. Sexually transmitted infections | ||||||
| 1.4.12.1.18. Tuberculosis, including intradermal testing and interpretation | ||||||
| 1.4.12.2. Therapies | ||||||
| 1.4.12.2.1. Spectrum of activity, adverse effects, and dose adjustments for antibiotics | ||||||
| 1.4.12.2.2. Antimicrobial stewardship | ||||||
| 1.4.12.2.3. Infection control in the hospital setting | ||||||
| 1.4.12.3. Malignancy | ||||||
| 1.4.12.3.1. Oncologic emergencies including, but not limited to: | ||||||
| 1.4.12.3.1.1. Hypercalcemia | ||||||
| 1.4.12.3.1.2. Spinal cord compression | ||||||
| 1.4.12.3.1.3. Superior vena cava syndrome | ||||||
| 1.4.12.3.1.4. Pleural and pericardial effusion | ||||||
| 1.4.12.3.1.5. Tumour lysis syndrome | ||||||
| 1.4.12.3.2. Screening and prevention | ||||||
| 1.4.12.3.3. Complications of chemotherapy including myelosuppression and hyperemesis | ||||||
| 1.4.12.3.4. Principles of diagnosis and treatment of the following: | ||||||
| 1.4.12.3.4.1. Breast cancer | ||||||
| 1.4.12.3.4.2. Ovarian cancer | ||||||
| 1.4.12.3.4.3. Endometrial and cervical cancer | ||||||
| 1.4.12.3.4.4. Urothelial cancer | ||||||
| 1.4.12.3.4.5. Prostate cancer | ||||||
| 1.4.12.3.4.6. Head and neck cancers | ||||||
| 1.4.12.3.4.7. Para-neoplastic syndromes | ||||||